Test Price
2,800 AED✅ Home Collection Available
NME8 Gene Primary Ciliary Dyskinesia Type 6 Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين NME8 لخلل الحركة الهدبية الأولي من النوع 6 في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي: تشخيص جيني دقيق لمرض خلل الحركة الهدبية الأولي من النوع 6 عبر تقنية التسلسل الجيني من الجيل التالي، مع خدمة سحب الدم في المنزل متوافقة مع معايير الجودة العالمية وقوانين دولة الإمارات.
- ✔ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited processing, detecting single nucleotide variants and copy number changes.
- ✔ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- ✔ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed genetic counsellor.
- ✔ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Comprehensive Test Overview
The NME8 Gene Primary Ciliary Dyskinesia Type 6 Genetic Test identifies pathogenic variants in the NME8 gene responsible for primary ciliary dyskinesia (PCD), a rare genetic disorder that impairs mucociliary clearance, leading to chronic respiratory infections, sinusitis, otitis media, and male infertility. يقوم هذا الاختبار بتحليل جين NME8 بدقة عالية باستخدام تقنية تسلسل الجيل التالي لتأكيد التشخيص وتوجيه خطة العلاج الشخصية.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) with CNV Analysis – full gene coverage | Sanger sequencing – limited to point mutations, misses large deletions/duplications |
| Sensitivity | >99.9% for single nucleotide variants & indels; >95% for CNVs | ~95% for point mutations only; no CNV detection |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Specimen | Whole blood or DNA FTA card (home collection available) | Whole blood only, lab visit required |
| Price (AED) | 2,800 | ~2,500 |
Physician Insight & Clinical Safety Protocol
“A genetic diagnosis of Primary Ciliary Dyskinesia type 6 provides clarity for patients and families who have endured years of unexplained respiratory distress and infertility. I remind every patient that this test must be correlated with clinical findings such as ciliary motility studies and high-resolution CT imaging. Do not discontinue prescribed medication without consulting your doctor.”
— Dr. PRABHAKAR REDDY, DHA-Licensed Medical Director (License: 61713011)
Patient Safety & Exclusion Criteria
- Exclusion: Active febrile illness, severe anemia (Hb < 8 g/dL), or current anticoagulant therapy that cannot be safely paused for blood draw.
- Deferral: Recent blood transfusion or stem cell transplant within 4 weeks (may affect DNA purity).
- Emergency Red Flags: If you experience acute worsening of cough, cyanosis, or severe shortness of breath, seek immediate medical attention at the nearest UAE hospital. Do not rely solely on scheduled genetic testing.
All genetic testing is performed at a DHA-licensed facility (License No. 9834453) in full compliance with Federal Decree-Law No. 41 of 2024 (Art. 87), the CDS Law 2026 for minors, and UAE PDPL data privacy standards. Informed consent is mandatory.
Frequently Asked Questions (Clinical Guidance)
1. What does a positive NME8 genetic test actually mean for my child's health?
A positive result confirms that two pathogenic variants in the NME8 gene are present, establishing the molecular cause of Primary Ciliary Dyskinesia type 6 and directing your physician toward targeted airway clearance therapies and regular monitoring. (النتيجة الإيجابية تؤكد وجود طفرات مرضية في جين NME8 وتشخص خلل الحركة الهدبية الأولي من النوع 6، مما يساعد في توجيه العلاج الفيزيائي التنفسي والمتابعة المنتظمة.)
2. Why is the NGS method preferred over older sequencing for this test?
Next-Generation Sequencing simultaneously evaluates the entire NME8 gene including deep intronic regions and copy number variations, which older methods miss, reducing the need for secondary testing. (يتميز تسلسل الجيل التالي بتحليل كامل لجين NME8 بما فيها المناطق العميقة والتغيرات في عدد النسخ، مما يقلل الحاجة لاختبارات إضافية ويوفر تشخيصاً شاملاً.)
3. How long will it take to get results and how are they delivered?
Results are typically available within 3–4 weeks and are delivered via a secure, encrypted patient portal with an option for a telephonic post- genetic counselling session included. (تظهر النتائج عادةً خلال 3-4 أسابيع، ويتم تسليمها عبر بوابة إلكترونية آمنة مع جلسة استشارة وراثية هاتفية عند الطلب.)
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians